|Illinois Racing Board
November 30, 2004
Contact: Mickey Ezzo, Mickey_Ezzo@irb.state.il.us
- Heading of the Part: Medication
- Code Citation: 11 Ill. Adm. Code 603
- Section Number: 603.70 Proposed Action: Amend
- Statutory Authority: 230 ILCS 5/9(b)
- Furosemide is a potent diuretic medication approved for use in racehorses that is helpful in the management of exercised induced pulmonary hemorrhage (EIPH). EIPH is a widespread and important cause of exercise intolerance in performance horses. Eighty-two to ninety-five percent of performance horses show signs of EIPH with repeated endoscopic exams.
The Board has sanctioned the use of furosemide as a race day medication for the past 21 years. Furosemide is strictly monitored by both pre-race and post-race procedures. Periodically, the medication rules must be updated to reflect current standards of practice and knowledge.
The proposed rulemaking only concerns the amount of furosemide that will be permitted to be used. The maximum allowable dosage would be raised from 250 millograms to 500 millograms. The 500 millograms is consistent with the model rules approved on April 3, 2004 by the Association of Racing Commissioners International (ARCI) and the North American Pari-Mutuel Regulators Association (NAPRA). The uniform drug rules approved by ARCI and NAPRA were based on veterinary and testing research conducted by the Racing Medication and Testing Consortium, a group made up of 25 industry organizations. The American Association of Equine Practitioners also supports the same dosage standards. In addition, several racing jurisdictions including New York permit 500 millograms as the maximum dosage of furosemide.
Pre and post-race supervision and time of administration will remain unchanged. The post-race serum quantitative levels, as well as penalties for excessive use, will be adjusted to reflect the dosage change.
In addition, the 9 day waiting period requirement for standardbred horses, found in Section 603.70(b)(1), will be reduced to 7 days for two reasons. First, the 7 days is more common amongst other racing jurisdictions and secondly, it is more in line with the normal racing schedule of a standardbred racehorse.
- Will these proposed amendments replace emergency amendments currently in effect? No.
- Does this rulemaking contain an automatic repeal date? No.
- Do these proposed amendments contain incorporation by reference? No.
- Are there any other proposed amendments pending in this Part? Yes, 28 Ill. Reg. 7533, effective December 1, 2004.
- Statement of Statewide Policy Objectives: No local governmental units will be required to increase expenditures.
- Time, Place and Manner in which interested persons may comment on this proposed rulemaking: Written comments should be submitted, within 45 days of this notice, to: Mickey Ezzo, Illinois Racing Board, 100 West Randolph, Suite 7-701, Chicago, Illinois 60601, (312) 814-5017.
- Initial Regulatory Flexibility Analysis:
- Types of small business affected: None
- Reporting, bookkeeping or other procedures required for compliance: None
- Types of professional skills necessary for compliance: None
- Regulatory Agenda which this rulemaking was summarized: This rulemaking was not included on either of the most recent two regulatory agendas because it was not anticipated when they were submitted.
TITLE 11: ALCOHOL, HORSE RACING, AND LOTTERY
SUBTITLE B: HORSE RACING
CHAPTER I: ILLINOIS RACING BOARD
SUBCHAPTER c RULES APPLICABLE TO ALL OCCUPATION LICENSEES
||Pre-Race Saliva Tests
||Racing Soundness Exam
||Foreign Substances and Pharmaceutical Aids Banned
||Twenty-four Hour Ban
||Prima Facie Evidence
||Permitted Use of Foreign Substances and Threshold Levels
||Needles, Syringes and Injectables
||Drugs, Chemicals and Prescription Items
||Laboratory Findings and Reports
||Distribution of Purses and Retention of Samples
||Carbon Dioxide Tests|
AUTHORITY: Authorized by Section 9(b) of the Illinois Horse Racing Act of 1975 [230 ILCS 5/9(b)].
SOURCE: Adopted at 21 Ill. Reg. 3232, effective March 4, 1997; amended at 22 Ill. Reg. 2217, effective January 1, 1998; amended at 22 Ill. Reg. 3594, effective February 1, 1998; amended at 25 Ill. Reg. 15611, effective December 1, 2001; amended at 26 Ill. Reg. 12360, effective August 1, 2002; amended at 27 Ill. Reg. 5027, effective March 7, 2003; amended at 27 Ill. Reg. 7331, effective April 15, 2003; amended at 28 Ill Reg. 1374, effective January 19, 2004; amended at 28 Ill. Reg. 15753, effective March 1, 2004; emergency amendment at 28 Ill. Reg. 7565, effective May 11, 2004, for a maximum of 150 days; amended at 28 Ill. Reg. 7533, effective December 1, 2004.
Section 603.70 Furosemide
(b) Veterinarian's List
(1) When a horse is added to the furosemide list, it shall be placed on the veterinarian's list and shall be ineligible to race for a minimum of 14 days. The 14 day ineligibility period begins on the certification date defined in subsections (c)(1)(A), (B), (C), and (D). During this 14 day period, the horse shall not be permitted to race with or without furosemide. Before the horse shall be permitted to enter a race, it must qualify on furosemide by participating in a qualifying race or by performing an official workout without bleeding, to the satisfaction of the State Veterinarian. Horses must wait
9 days following the certification date before participating in a qualifying race.
(e) Administration of Furosemide
(3) A Board licensed veterinarian shall administer not less than 150 mg and not more than
250 mg of furosemide intravenously and shall verify the administration on prescribed affidavits before the post time of the first race.
(g) Excessive Use of Furosemide
(1) The test level for furosemide shall not be in excess of
60 nanograms (ng) per milliliter (ml) of serum or plasma.
(2) The first two times the laboratory reports an amount of furosemide equal to 61ng - 85ng/ml, inclusive, the trainer shall receive a written warning. For each subsequent overage at this level by the same trainer, the trainer shall be fined no more than $200.
(3) The first time the laboratory reports an amount of furosemide, equal to 86ng - 99ng/ml, inclusive, the trainer shall receive a written warning. For each subsequent overage at this level by the same trainer, the trainer shall be fined no more than $500 and suspended not more than 30 days.
(4) In the event a post-race sample contains an amount of furosemide greater than 99ng/ml, the trainer shall be fined no more than $2500 and/or suspended no more than 60 days and the purse shall be redistributed.
(5) When imposing penalties, the stewards shall consider the factors found in subsections 603.160(3), (4), (5) and (6).